Northwest Biotherapeutics: Q1 Earnings Snapshot
BETHESDA, Md. (AP) _ Northwest Biotherapeutics Inc. (NWBO) on Tuesday reported a loss of $14.2 million in its first quarter.
On a per-share basis, the Bethesda, Maryland-based company said it had a loss of 1 cent.
The cancer drug developer posted revenue of $403,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO